121 related articles for article (PubMed ID: 1535736)
1. Markers of procoagulant imbalance in patients with inherited thrombophilic syndromes.
Mannucci PM; Tripodi A; Bottasso B; Baudo F; Finazzi G; De Stefano V; Palareti G; Manotti C; Mazzucconi MG; Castaman G
Thromb Haemost; 1992 Feb; 67(2):200-2. PubMed ID: 1535736
[TBL] [Abstract][Full Text] [Related]
2. Measurement of markers of activated coagulation in antithrombin III deficient subjects.
Demers C; Ginsberg JS; Henderson P; Ofosu FA; Weitz JI; Blajchman MA
Thromb Haemost; 1992 May; 67(5):542-4. PubMed ID: 1519214
[TBL] [Abstract][Full Text] [Related]
3. Plasma protein oxidation is associated with an increase of procoagulant markers causing an imbalance between pro- and anticoagulant pathways in healthy subjects.
De CR; Rocca B; Marchioli R; Landolfi R
Thromb Haemost; 2002 Jan; 87(1):58-67. PubMed ID: 11848457
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of prothrombin activation fragment 1 + 2 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency.
Zöller B; Holm J; Svensson P; Dahlbäck B
Thromb Haemost; 1996 Feb; 75(2):270-4. PubMed ID: 8815575
[TBL] [Abstract][Full Text] [Related]
5. Two cases of inherited triple deficiency in a large kindred with thrombotic diathesis and deficiencies of antithrombin III, heparin cofactor II, protein C and protein S.
Jobin F; Vu L; Lessard M
Thromb Haemost; 1991 Sep; 66(3):295-9. PubMed ID: 1836072
[TBL] [Abstract][Full Text] [Related]
6. [Prothrombin fragment 1+2 (F1+2), thrombin-antithrombin III complex(TAT) and thrombophilia parameters in orally anticoagulated patients with inferior vena cava filters].
Halbmayer WM; Haushofer A; Toth E
Wien Med Wochenschr; 1993; 143(5):95-8. PubMed ID: 8511904
[TBL] [Abstract][Full Text] [Related]
7. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
Herren T; Straub PW; Haeberli A
Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
[TBL] [Abstract][Full Text] [Related]
8. Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo.
Eichinger S; Wolz M; Nieszpaur-Los M; Schneider B; Lechner K; Eichler HG; Kyrle PA
Thromb Haemost; 1994 Dec; 72(6):831-5. PubMed ID: 7740450
[TBL] [Abstract][Full Text] [Related]
9. Hemostasis activation in thrombophilic subjects with or without a history of venous thrombosis.
Cuderman TV; Bozic M; Peternel P; Stegnar M
Clin Appl Thromb Hemost; 2008 Jan; 14(1):55-62. PubMed ID: 17895509
[TBL] [Abstract][Full Text] [Related]
10. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
[TBL] [Abstract][Full Text] [Related]
11. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].
Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M
Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836
[TBL] [Abstract][Full Text] [Related]
12. Recurrent venous thrombosis and hypercoagulable states.
Bolan CD; Alving BM
Am Fam Physician; 1991 Nov; 44(5):1741-51. PubMed ID: 1835274
[TBL] [Abstract][Full Text] [Related]
13. Coagulation activation following estrogen administration to postmenopausal women.
Caine YG; Bauer KA; Barzegar S; ten Cate H; Sacks FM; Walsh BW; Schiff I; Rosenberg RD
Thromb Haemost; 1992 Oct; 68(4):392-5. PubMed ID: 1333098
[TBL] [Abstract][Full Text] [Related]
14. Thrombophilic variables do not increase the generation or procoagulant activity of thrombin during cardiopulmonary bypass.
Raivio P; Petäjä J; Kuitunen A; Lassila R
Ann Thorac Surg; 2008 Feb; 85(2):536-42. PubMed ID: 18222259
[TBL] [Abstract][Full Text] [Related]
15. [Natural anticoagulants as a cause of hereditary familial thrombosis].
Tripodi A; Mannucci PM
Haematologica; 1990; 75 Suppl 2():1-5. PubMed ID: 2143743
[No Abstract] [Full Text] [Related]
16. Enhanced thrombin generation in children with sickle cell disease.
Peters M; Plaat BE; ten Cate H; Wolters HJ; Weening RS; Brandjes DP
Thromb Haemost; 1994 Feb; 71(2):169-72. PubMed ID: 8191393
[TBL] [Abstract][Full Text] [Related]
17. Correlates of antithrombin, protein C, protein S, and TFPI in a healthy elderly cohort.
Sakkinen PA; Cushman M; Psaty BM; Kuller LH; Bajaj SP; Sabharwal AK; Boineau R; Macy E; Tracy RP
Thromb Haemost; 1998 Jul; 80(1):134-9. PubMed ID: 9684799
[TBL] [Abstract][Full Text] [Related]
18. Plasma concentrations of the natural anticoagulants protein C and protein S in patients with proteinuria.
Cosio FG; Harker C; Batard MA; Brandt JT; Griffin JH
J Lab Clin Med; 1985 Aug; 106(2):218-22. PubMed ID: 3160800
[TBL] [Abstract][Full Text] [Related]
19. Different incidence of venous thrombosis in patients with inherited deficiencies of antithrombin III, protein C and protein S.
Finazzi G; Barbui T
Thromb Haemost; 1994 Jan; 71(1):15-8. PubMed ID: 8165635
[TBL] [Abstract][Full Text] [Related]
20. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin.
Brouwer JL; Lijfering WM; Ten Kate MK; Kluin-Nelemans HC; Veeger NJ; van der Meer J
Thromb Haemost; 2009 Jan; 101(1):93-9. PubMed ID: 19132194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]